Create Alert
Watchlist

Dr Reddy's Laboratories

5749.40
-38.75 (0.67%) 1D
NSE
1D
1W
1M
1Y
3Y
5Y
All

Performance

Open
5,800.00
Prev. Close
5,788.15
Volume
2,78,300
Total traded value
160 Cr
Upper Circuit
6,324.30
Lower Circuit
5,174.50

Market Depth

Buy order quantity
Sell order quantity
%
%
Loading...
Bid Total
15
Loading...
Ask Total
0

Analyst Estimates

51%
Buy
51%
Hold
22%
Sell
27%
Aggregated by Refinitiv from 37 Analysts

Fundamentals

Market Cap₹95,867Cr
ROE19.97%
P/E Ratio(TTM)18.83
EPS(TTM)305.23
P/B Ratio3.76
Dividend Yield0.70%
Industry P/E32.29
Book Value1528.58
Debt to Equity0.05
Face Value5
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Dr Reddy's Labs

Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily consists of the Company’s business of manufacturing and marketing APIs and intermediates. The Global Generics segment consists of the Company’s business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).;
Parent OrganisationDr Reddy's Laboratories Limited
Founded1984
Managing DirectorMr. Gunupati Prasad
NSE SymbolDRREDDY

Shareholding Pattern

Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Foreign Institutions
28.19%
Promoters
26.66%
Retail And Others
26.39%
Other Domestic Institutions
10.15%
Mutual Funds
8.61%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
₹1,236.15
(+0.40%)
34.56
Cipla
₹1,205.70
(-0.54%)
28.21
Mankind Pharma
NA
(0.00%)
49.31
Torrent Pharmaceuticals
₹2,150.75
(-0.02%)
54.22
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW